conjunctival scars

H7_CONJUNCTSCAR

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H11.2 Hospital discharge: ICD-9 — 3726 Hospital discharge: ICD-8 — 37821 Cause of death: ICD-10 — H11.2 Cause of death: ICD-9 — 3726 Cause of death: ICD-8 — 37821 2 out of 7 registries used, show all original rules.	76
4. Check minimum number of events None	76
5. Include endpoints None	76
6. Filter based on genotype QC (FinnGen only)	67

Control definitions (FinnGen only)

Control exclude: H7_CONJUNCTIVA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H11
Name in latin: Cicatrix/cicatrices conjunctivae

NAME	H7_CONJUNCTSCAR
CONTROL_EXCLUDE	H7_CONJUNCTIVA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H112
HD_ICD_9	3726
HD_ICD_8	37821
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H112
COD_ICD_9	3726
COD_ICD_8	37821
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to conjunctival scars based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	517	276	238
Only index persons	461	254	207
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	51.16	50.27	52.30
Only index persons	50.33	48.96	52.02

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	67	45	22
Unadjusted period prevalence (%)	0.01	0.02	0.01
Median age at first event (years)	50.86	50.57	51.45

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
68: Matched controls
680

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H11.2

ICD-10 Finland

Conjunctival scars

+∞

81.5

H04.10

ICD-10 Finland

Dry eye syndrome

6.8

10.9

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

5.2

10.5

133

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

5.1

9.6

198

CFD10

NOMESCO Finland

Repair of conjunctiva

+∞

9.6

H02.0

ICD-10 Finland

Entropion and trichiasis of eyelid

19.2

7.0

CFC00

NOMESCO Finland

Excision of lesion of conjunctiva

44.6

6.9

CBG00

NOMESCO Finland

Epilation of cilia by electrolysis

76.8

6.5

S01XA18

ATC

ciclosporin; ophthalmic

+∞

6.3

CFA20

NOMESCO Finland

Biopsy of conjunctiva

+∞

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

4.30

6.72

2.1

1.7

—

(3032080) INR in Blood by Coagulation assay

261

2.94

4.35

10.6

9.5

1.26

1.14

inr

0.70

209

(3042936) Bacteria identified in Isolate by Culture

2.66

2.85

2.3

2.0

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

3.25

2.72

2.4

4.5

74.60

60.36

ml/min/173m2

—

(42870588) Differential panel, method unspecified - Blood

197

2.18

2.49

7.3

7.2

—

(3023368) Bacteria identified in Blood by Culture

159

2.16

2.32

3.7

4.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

104

2.31

4.2

3.4

20.92

92.53

ng/l

0.52

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2.98

2.02

5.2

10.3

0.90

0.64

—

(3044640) Blood type and Crossmatch panel - Blood

202

1.98

2.9

2.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

151

2.04

1.97

2.2

2.4

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2.81

1.88

5.2

10.0

1.34

1.49

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2.81

1.88

5.2

10.0

93.22

92.67

—

(3034770) Mitochondria Ab [Titer] in Serum

3.76

1.88

1.3

1.6

—

(40768804) Tissue Pathology biopsy report

225

1.91

1.81

2.3

2.0

—

(3018010) Neutrophils/Leukocytes in Blood

295

1.86

1.68

7.1

7.7

57.70

56.95

0.17

286

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

3.76

1.64

1.8

1.2

—

(3022145) Colonoscopy Study observation

2.24

1.61

1.3

1.4

—

(3019977) pH of Arterial blood

2.24

1.61

5.4

7.2

7.41

7.43

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

350

1.84

1.54

9.8

10.9

4.44

3.84

e9/l

0.99

306

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2.67

1.49

2.1

2.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1.99

1.44

1.4

1.7

872.58

1148.21

nmol/l

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

3.09

1.38

1.2

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

288

1.72

1.36

3.1

2.7

—

estimate

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.53

1.34

7.8

12.1

25.26

25.76

mmol/l

—

(36660697) Celiac disease serology panel - Serum

2.15

1.30

1.6

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2.53

1.27

5.3

2.4

25.72

23.71

mmol/l

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2.76

1.24

1.6

1.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.94

1.16

3.6

9.0

105.77

104.07

mmol/l

0.71

(3006315) Basophils [#/volume] in Blood

318

1.63

1.12

6.7

7.3

0.06

0.04

e9/l

2.22

275

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

389

1.67

1.12

3.3

3.1

—

(3001604) Monocytes [#/volume] in Blood

319

1.62

1.09

6.1

7.3

0.61

0.55

e9/l

1.35

278

(40758558) Short blood count panel - Blood

178

1.64

1.08

5.2

7.9

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2.37

1.05

2.2

3.0

96.00

96.91

—

(3019060) Gas panel - Arterial blood

2.11

1.03

2.7

3.7

—

(3000991) Gas panel - Venous blood

1.92

1.01

7.0

10.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2.05

1.00

4.0

6.2

127.00

131.00

g/l

—

(3019198) Lymphocytes [#/volume] in Blood

325

1.56

0.97

6.7

7.3

1.87

1.81

e9/l

0.21

288

(3013115) Eosinophils [#/volume] in Blood

325

1.56

0.97

6.9

7.6

0.22

0.18

e9/l

0.57

287

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

542

1.91

0.97

4.0

1.29

1.26

mmol/l

0.09

504

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2.02

0.92

3.1

2.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.88

0.88

1.6

1.9

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.70

0.82

1.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

126

1.58

0.81

1.7

1.9

1.95

1.06

mg/l

0.33

104

(3021960) Folate [Moles/volume] in Serum or Plasma

155

1.51

0.75

1.3

1.7

21.54

22.62

nmol/l

0.12

135

(3022313) Gas panel - Capillary blood

2.08

0.74

2.4

3.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.99

0.72

1.2

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.78

0.65

1.4

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.61

0.62

2.5

3.3

—

(3000494) Fungus identified in Specimen by Culture

1.60

0.60

1.2

1.5

—

(40768793) Breast Pathology biopsy report

0.00

0.59

0.0

1.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

211

1.38

0.55

4.2

3.4

17.39

43.51

ng/l

0.77

149

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.59

0.54

2.3

1.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.59

0.54

1.2

1.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

250

1.36

0.54

2.2

1.9

1.38

1.23

mmol/l

0.56

210

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

572

1.64

0.54

5.3

4.7

1.50

mmol/l

0.00

534

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

574

1.61

0.54

5.2

4.8

4.78

4.66

mmol/l

0.37

537

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

110

0.60

0.54

1.6

1.4

—

(3013512) EKG study

196

1.35

0.48

4.2

3.3

—

(4035726) Immunohistochemistry procedure

1.53

0.47

1.5

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1.61

0.43

1.6

1.4

0.21

0.23

g/l

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1.61

0.43

1.6

1.4

1.27

1.21

g/l

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1.61

0.43

2.2

6.8

0.64

0.59

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1.61

0.43

2.4

6.9

0.62

1.25

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.42

0.0

1.1

—

2.50

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.4

—

44.72

—

(3035933) Granulocytes/Leukocytes in Blood

0.00

0.41

0.0

3.1

—

66.84

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

116

1.38

0.41

1.5

1.7

—

(4034850) Laboratory test

0.00

0.40

0.0

8.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

135

1.35

0.40

1.9

1.8

—

(1761868) Lipid panel - Serum or Plasma

240

0.76

0.40

3.8

3.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.00

0.39

0.0

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.00

0.39

0.0

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.00

0.39

0.0

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

0.00

0.39

0.0

1.8

—

6.99

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

461

1.32

0.39

11.0

8.5

86.84

80.58

u/l

0.41

432

(3026008) Bacteria identified in Urine by Culture

187

0.75

0.39

5.3

3.0

—

(3009508) Creatinine [Moles/volume] in Urine

212

1.28

0.38

3.3

2.9

7.08

8.26

mmol/l

0.75

173

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

118

1.35

0.37

1.5

1.3

1.03

3.30

u/ml

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

118

1.35

0.37

1.7

1.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1.39

0.37

2.5

3.8

0.79

0.81

mmol/l

0.26

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.40

0.35

1.0

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

583

1.45

0.33

5.7

5.4

2.78

2.71

mmol/l

0.24

547

(3007164) IgA [Mass/volume] in Serum or Plasma

139

1.30

0.33

2.1

1.4

2.59

2.25

g/l

—

(3021440) Promyelocytes/Leukocytes in Blood

1.39

0.32

3.6

7.2

—

0.24

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

294

1.24

0.32

6.7

8.0

1.18

1.22

mmol/l

2.06

250

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

564

1.35

0.30

5.2

4.5

6.03

5.75

mmol/l

0.40

526

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.37

0.30

1.3

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

1.33

0.28

3.7

2.8

589.82

124.61

ug/g

0.51

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

114

1.29

0.28

2.9

2.45

2.44

mmol/l

0.04

102

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.29

0.27

1.3

1.6

—

(3003694) ABO and Rh group [Type] in Blood

192

1.22

0.25

1.3

1.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1.29

0.25

1.3

3.2

0.43

2.12

e6/l

—

(3029937) Albumin [Presence] in Urine by Test strip

177

0.80

0.24

3.9

4.0

0.00

estimate

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1.34

0.24

1.2

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

252

1.19

0.23

2.0

81.00

93.18

pmol/l

0.65

120

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

194

1.20

0.22

2.8

2.7

58.68

75.18

u/l

0.26

181

(40768797) Stomach Pathology biopsy report

1.29

0.22

1.0

1.2

—

(4195642) Thrombophilia screening test

0.00

0.21

0.0

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.21

0.0

1.0

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.21

0.0

1.1

—

97.10

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.21

0.0

1.4

—

(4268621) Lupus anticoagulant assay

0.00

0.21

0.0

2.2

—

(3012516) Albumin [Mass/volume] in Urine

195

1.19

0.21

3.5

3.1

31.26

40.45

mg/l

0.28

121

(3000492) Spirometry study

1.27

0.21

1.5

1.6

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

560

1.24

0.18

19.1

15.2

81.58

82.28

ml/min/173m2

0.07

512

(21494755) Public health laboratory ask at order entry panel

1.16

0.17

1.4

1.3

—

(3018095) Leukocytes [#/volume] in Urine

232

0.86

0.16

3.0

4.0

24.88

69.99

e6/l

0.59

162

(3002256) Pathology report gross observation

1.24

0.16

1.4

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

553

1.19

0.14

6.6

5.7

39.95

38.60

mmol/mol

0.38

520

(3026782) Osmolality of Urine

114

1.17

0.13

3.7

2.8

580.00

517.55

mosm/kgh2o

0.35

103

(3021589) Normoblasts [#/volume] in Blood

272

1.12

0.11

11.4

12.3

0.00

e9/l

0.71

225

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.15

0.10

1.0

1.5

—

(40761536) Microorganisms panel - Urine sediment

1.12

0.10

6.0

3.1

—

(3022621) pH of Urine by Test strip

1.06

0.09

4.5

2.5

6.08

6.24

—

(3020682) Albumin/Creatinine [Ratio] in Urine

196

1.10

0.08

4.1

3.7

3.70

6.86

mg/mmol

0.73

119

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.82

0.08

1.5

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

324

0.92

0.07

5.0

4.0

0.00

estimate

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1.13

0.07

2.9

0.89

0.69

ug/l

—

(40760892) CBC W Ordered Manual Differential panel - Blood

149

1.10

0.06

4.9

6.3

—

(3035350) Ketones [Presence] in Urine by Test strip

322

0.93

0.06

4.9

3.9

0.00

estimate

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

201

0.92

0.05

5.2

3.4

2.37

2.36

mmol/l

0.05

182

(3021601) Nitrite [Presence] in Urine by Test strip

320

0.94

0.04

4.9

3.9

0.00

estimate

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

102

1.09

0.03

1.6

1.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

244

1.04

0.00

4.7

3.7

0.00

0.02

estimate

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

122

0.98

0.00

2.8

4.3

20.00

22.94

—

(3000850) Epithelial cells [#/volume] in Urine

132

0.98

0.00

2.2

2.6

10.33

5.61

e6/l

0.40

123

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

103

0.97

0.00

1.5

3.1

0.20

0.95

e6/l

—

(3015736) pH of Urine

257

1.02

0.00

3.5

3.4

6.03

6.19

0.30

146

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

512

0.98

0.00

25.2

18.2

13.66

13.55

0.22

512

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

212

0.99

0.00

2.4

3.3

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

5.8

—

17.13

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

0.93

-0.00

1.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.86

-0.00

5.5

6.2

—

(3035715) Granulocytes [#/volume] in Blood

0.00

-0.00

0.0

2.9

—

5.85

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

-0.00

0.0

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.96

-0.00

1.9

1.8

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

0.00

-0.00

0.0

1.8

—

0.43

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.01

-0.00

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.86

-0.00

1.2

1.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

3.6

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

-0.00

0.0

2.2

—

32.78

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

-0.00

0.0

1.1

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

-0.00

0.0

2.0

—

1113.86

—

(3005570) Glucose [Moles/volume] in Urine

0.00

-0.00

0.0

3.0

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

16.45

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

55.50

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

0.50

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3006245) CD3-CD19+ cells/cells in Blood

0.00

-0.00

0.0

3.2

—

6.60

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

9.0

—

0.61

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

0.00

-0.00

0.0

2.6

—

28.60

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

-0.00

0.0

2.8

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

-0.00

0.0

2.2

—

7.26

—

(3035320) C reactive protein [Mass/volume] in Body fluid

0.00

-0.00

0.0

1.6

—

70.60

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3034988) Calcium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

4.0

—

1.20

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

27.28

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(4281824) Cell count and differential, peritoneal fluid

0.00

-0.00

0.0

1.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_CONJUNCTSCAR and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have H7_CONJUNCTSCAR.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: H7_CONJUNCTSCAR – conjunctival scars

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

conjunctival scars

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints